Pharming Group N.V. earnings
Annual earnings per share (USD per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0.00 | $0.00 | 2026-06-19T06:31:07Z |
| 2024 | 2024-12-31 | $-0.02 | $-0.02 | 2026-06-19T06:31:07Z |
Revenue & profit (USD)
| Concept | 2025 | 2024 |
|---|---|---|
| Revenue | $376.1M | $297.2M |
| Profit for the year | $2.5M | -$11.8M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in Pharming Group N.V.'s ESEF annual reports (source:
filings.xbrl.org).
Figures are in USD, as reported. Not investment advice.